A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s DiseaseThomas Billiet, Séverine Vermeire, Isabelle Cleynen et al.|Journal of Crohn s and Colitis|2015Cited by 71
A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn’s Disease: A Population-based StudyHélène Sarter, C Bernou-Dron, Guillaume Savoye et al.|Inflammatory Bowel Diseases|2023Cited by 7